e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Predictors of lung transplant complications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alveolar macrophages and pulmonary microbiota are interconnected indicators of lung ecology post-transplantation
Eric Bernasconi (Lausanne, Switzerland), Eric Bernasconi, Angela Koutsokera, Celine Pattaroni, Berutto Carine, Boubou Camara, Benjamin J. Marsland, Christian Benden, Christophe Pison, John-David Aubert, Laurent P. Nicod, SysCLAD FP7 Consortium
Source:
International Congress 2015 – Predictors of lung transplant complications
Session:
Predictors of lung transplant complications
Session type:
Oral Presentation
Number:
3269
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Eric Bernasconi (Lausanne, Switzerland), Eric Bernasconi, Angela Koutsokera, Celine Pattaroni, Berutto Carine, Boubou Camara, Benjamin J. Marsland, Christian Benden, Christophe Pison, John-David Aubert, Laurent P. Nicod, SysCLAD FP7 Consortium. Alveolar macrophages and pulmonary microbiota are interconnected indicators of lung ecology post-transplantation. Eur Respir J 2015; 46: Suppl. 59, 3269
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Bronchoalveolar lavage (techniques, indications, results)
Altered microRNA profiles in the bronchoalveolar lavage fluid exosomes in asthma and COPD
Related content which might interest you:
Interactive plasticity of alveolar macrophages and microbiota in lung transplant recipient
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Phenotypes of alveolar macrophages in normal human lung and their polarization with disease
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Differential sensitivity of subsets of monocyte-derived macrophages to apoptosis; its impact on lung inflammation
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Alveolar type II cells transplantation in pulmonary fibrosis: Effect on the lung macrophage activation
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
Impaired HGF-production by alveolar macrophages is a feature of diabetic pneumonia
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013
Functional phenotype of immune response and alveolar macrophages phenotype in pulmonary sarcoidosis
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Alveolar macrophage in protracted bacterial bronchitis
Source: International Congress 2016 – Airway response to infection
Year: 2016
Characterization of M1 and M2 macrophages in human lung tissue
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
The effect of budesonide on TLR expression in alveolar macrophages from smokers
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Biomass smoke particles induce cytokines and reduce phagocytosis by monocyte-derived macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Evidence for a replicative intracellular stage of staphylococcus aureus in alveolar macrophages
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Zinc and zinc transporters in human alveolar and THP-1 macrophages and roles in phagocytosis/efferocytosis
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF alveolar macrophages
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Induced pluripotent stem cells conditioned media (iPS-cm) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
CFTR-dependent deficiency in alternatively-activated macrophages in cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Hyperoxia impairs the inflammatory response of alveolar macrophages to multiple Toll-like receptor ligands associated with bacterial infection
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
Effect of JQ-1 on monocyte-derived macrophage (MDM) phagocytosis of bacteria and cytokine release
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept